Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Permanyer
2022-07-01
|
| Серія: | Gaceta Mexicana de Oncología |
| Предмети: | |
| Онлайн доступ: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|